0001183740-16-000419.txt : 20160922 0001183740-16-000419.hdr.sgml : 20160922 20160922133504 ACCESSION NUMBER: 0001183740-16-000419 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160922 DATE AS OF CHANGE: 20160922 EFFECTIVENESS DATE: 20160922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-271117 FILM NUMBER: 161897323 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 D 1 primary_doc.xml X0707 D LIVE 0001374339 ProMIS Neurosciences Inc. SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 416-847-6898 CANADA (FEDERAL LEVEL) AMORFIX LIFE SCIENCES LTD Corporation true ELLIOT GOLDSTEIN SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director JOHANNES MINHO ROTH SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Director NEIL CASHMAN SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director WILLIAM WYMAN SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Director EUGENE WILLIAMS SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Executive Officer Director PATRICK KIRWIN SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Director JANET CLENNETT SUITE 200, 1920 YONGE STREET TORONTO A6 ONTARIO, CANADA M4S 3E2 Executive Officer Biotechnology Decline to Disclose 06b false 2016-09-09 true true true true false 0 CIBC WORLD MARKETS CORP. 630 None None 22 Front Street W. 4th Floor Toronto A6 ONTARIO, CANADA M5J 2W5 All States false 282721 206310 76411 Total Offering Amount equals the price of units (1,977,062 units @ C$0.135), plus the aggregate exercise price of warrants forming part of the units (494,267 warrants @ C$0.20), converted to US$. false 7 0 2087 Finder' Fees represent cash fee of C$2,700, converted to US$. Recipient under Item 12 also received 18,000 warrants each exercisable into a common share of the Issuer @ C$0.20. 0 false ProMIS Neurosciences Inc. /s/ Janet Clennett Janet Clennett Director Finance, Acting CFO 2016-09-20